Regarding the management of nasopharyngeal angiofibroma, all of the following statements are correct EXCEPT:

Explanation

## Management of Nasopharyngeal Angiofibroma **Key Point:** Surgery is the gold standard and first-line definitive treatment for NAF. Radiation therapy is NOT first-line and is reserved for recurrent, unresectable, or metastatic disease. ### Treatment Algorithm ```mermaid flowchart TD A[Nasopharyngeal Angiofibroma Diagnosed]:::outcome --> B{Extent & Operability?}:::decision B -->|Small-Moderate| C[Preoperative Embolization]:::action B -->|Large/Recurrent| D[Consider Neoadjuvant Therapy]:::action C --> E[Endoscopic Resection]:::action D --> F[Embolization + Surgery OR Radiation]:::action E --> G[Complete Excision with Margins]:::outcome F --> H{Complete Response?}:::decision H -->|Yes| I[Surveillance]:::action H -->|No| J[Radiation Therapy for Recurrence]:::action ``` ### Surgical Management (First-Line) **High-Yield:** Surgery is the definitive treatment. The goal is complete excision with adequate margins to minimize recurrence. | Aspect | Details | | --- | --- | | **Approach** | Endoscopic (preferred for small-moderate tumors); open approaches (lateral rhinotomy, midfacial degloving) for large/extensive disease | | **Preoperative embolization** | Reduces blood loss by 50–80%; improves surgical field; performed 24–48 hours before surgery | | **Feeding vessels** | Sphenopalatine artery (primary), internal maxillary, ascending pharyngeal | | **Margin status** | Wide local excision essential; incomplete excision → high recurrence | **Clinical Pearl:** Endoscopic resection has become the standard approach in modern practice because it offers excellent visualization, reduced morbidity, and comparable recurrence rates to open approaches when combined with preoperative embolization. ### Adjunctive & Salvage Therapies 1. **Preoperative embolization:** Reduces intraoperative hemorrhage and improves visualization — CORRECT statement 2. **Endoscopic resection:** Preferred approach for small to moderate tumors — CORRECT statement 3. **Hormonal therapy:** Estrogen antagonists (e.g., tamoxifen) or GnRH agonists may be used in select cases (recurrent, unresectable, or poor surgical candidates) — CORRECT statement 4. **Radiation therapy:** Reserved for: - Recurrent disease after surgery - Unresectable tumors - Metastatic disease - Poor surgical candidates - NOT first-line treatment **Warning:** Radiation therapy is NOT the first-line definitive treatment. It is a salvage option and carries risks of secondary malignancy, especially in young patients. ### Why Option 3 is Incorrect Radiation therapy is explicitly NOT first-line. Surgery with preoperative embolization is the gold standard. Radiation is reserved for recurrent, unresectable, or metastatic disease. Stating that radiation is "preferred over surgery to avoid recurrence" is fundamentally incorrect — surgery with complete excision is the most effective way to prevent recurrence. [cite:Dhingra's Diseases of Ear Nose and Throat Ch 15; Park Textbook of Preventive and Social Medicine 26e]